Good Blood develops and markets new technological products to be used in health care. The development of a new product operates as follows: The technology is first patented. Once the patent is approved and received, the technology waits for an available development center. Once the center becomes available, the technology undergoes development in that center. Good Blood has 5 independent centers. On average, Good Blood receives a new patent every 9 months with a standard deviation of 12 months. The average development process lasts 36 months (with a standard deviation of 24 months). Once the technology is developed, it is then launched in the market. 1. What is the utilization of Good Blood development centers? 2. On Average how long (In Months) does it take for the technology to Start the development process (At a development Center) after receiving the patent?